Related Experiment Videos
[Acute renal failure in patients with hematologic neoplasms]
S Okada1, Y Miyoshi, Y Takizawa
1Department of Hematology, Fujigaoka Hospital, Showa University.
Summary
Acute renal failure (ARF) in hematologic neoplasms has a high mortality rate. Early blood purification therapy may improve outcomes for these critically ill patients.
Area of Science:
- Nephrology
- Hematology
- Oncology
Context:
- Acute renal failure (ARF) is a serious complication in patients with hematologic neoplasms.
- This retrospective study analyzed ARF incidence, causes, and outcomes in 526 hematologic neoplasm patients.
Purpose:
- To investigate the characteristics and prognosis of ARF in patients with hematologic neoplasms.
- To identify factors influencing survival and the potential benefit of early interventions.
Summary:
- ARF occurred in 6.1% of patients, with a high mortality rate (78%).
- Causes varied by hematologic malignancy, including sepsis, DIC, and tumor lysis syndrome.
- Survival depended on the underlying disease and ARF cause, not solely renal function.
Impact:
- Findings highlight the critical nature of ARF in this patient population.
- Suggests early blood purification therapy, alongside chemotherapy, may improve prognosis.
- Emphasizes the need for tailored management strategies based on specific hematologic diagnoses.